Alarming Rise of Vestibular Disorders in Geriatric Population Drives Global Vestibular Testing System Market Growth:  Fact.MR

Surging number of patients suffering from dizziness disorder, balance disorder and vertigo along with adoption of technologically advanced medical treatment are the primary sales drivers.

Fact.MR, Rockville MD:  Global vestibular testing system market is forecast to register 6.8% CAGR for the forecast period 2018-2028. According to market research firm Fact.MR, availability of videonystagmography at low cost for the treatment of Meniere’s disease and advancement in vestibular testing technologies are the leading growth parameters. Development in health infrastructure in developing countries along with government run awareness programs and desired reimbursement policies will elevate the vestibular testing system market demands.

“Surge is witnessed in children suffering from balance disorder and vertigo. Usage of Vestibular Testing System in developing treatment for vestibular diseases is expected to increase the market growth. The introduction of vestibular therapy initiative will lead to patient awareness regarding vestibular diseases enhancing the market growth,” said a lead analyst at Fact MR

Request sample of the report on the Vestibular Testing System Market

https://www.factmr.com/connectus/sample?flag=S&rep_id=1313

Vestibular testing system market – Key findings

  • Vestibular testing system market is forecast to reach the valuation of US$ 79.6 Mn in global market.
  • 30% of global geriatric population suffers for vestibular diseases like vertigo and dizziness disorder.
  • 70% of global vestibular testing system market shares comprises of North America, Western Europe, and Asia Pacific markets.
  • Asia Pacific excluding China and Japan are forecast to grow at 8% CAGR by the end of 2028.
  • Market in Japan is expected to grow at 7.8% CAGR by the end of 2028.

Explore 27 tables and 150 figures of the study. Request ToC of the report at

https://www.factmr.com/report/1313/vestibular-testing-market

Vestibular testing system market – Key Driving Factors

  • Development of health infrastructures in emerging economies and increased spending on healthcare are leading market drivers.
  • Technological advancement and adoption of high accuracy vestibular testing devices for the treatment of dizziness, vertigo and balance disorders boosted the growth.
  • Demands from emerging economies and developing healthcare systems are providing better growth opportunities.

Vestibular testing system market - Major Restraints

  • Lack of awareness related to vestibular diseases in developing countries and limited presence of top market players restricts the market growth.
  • High Vestibular testing device cost and expensive supporting tests hampers the market growth.

Covid-19 Impact

COVID-19 pandemic damaged the global healthcare system and disrupted the necessary supply chain of drugs and medicines. It has negatively impacted on vestibular testing system market. Only medical supplies and life support product industries were permitted due to lockdown and other restrictions. This hampered the vestibular testing system market. Pandemic also slowed the world market growth and with few key market players operating during the pandemic, slowed the market growth.

The growth is estimated to increase with relaxations in lockdown and clearance of work stoppage orders.

Competitive Landscape

Some of the key players working in the global vestibular testing system market are BioMed Jena GmbH, balanceback (Vestibular Research & Development, LLC), Interacoustics A/S,  Natus Medical Incorporated,  Micromedical Technologies, Framiral, Synapsys, Neuro Kinetics, Difra s.a. and TECHNO CONCEPT etc.

The market players are actively participating in strategic mergers and acquisition and are also running awareness campaigns among the healthcare providers. This strategy will assist them in launching of modern vestibular testing systems as well as expanding in emerging markets.

More Insights on the Vestibular testing system market

In its latest report, Fact.MR offers unbiased analysis of the vestibular testing system market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (Vestibular evoked myogenic potential (VEMP) System, Videonystagmography (VNG) Systems, Rotary Chair, Computerized Dynamic Posturography (CDP)) and end user (hospitals, private clinics) across seven regions (North America, Latin America, Europe, Japan, Asia Pacific excluding Japan, China and Middle East & Africa).

 

Request more information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=1313

Explore Fact.MR’s Coverage on the Healthcare Domain

Electronystagmography testing Market: A recent study by Fact.MR on the Electronystagmography testing market offers a 10-year forecast analysis for the period 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Carbapenem-resistant Enterobacteriaceae testing Market: Fact. MR’s extensive coverage on the Carbapenem-resistant Enterobacteriaceae testing Market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Influenza A/B combo testing market: The global Influenza A/B combo testing market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.  

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.   

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Back to news